> Videos > The Latest in Genetic Testing

The Latest in Genetic Testing

Genetic Testing in Prostate Cancer: What It Means for Your Treatment — and Your Family

PCF Chief Medical Officer Dr. Phillip Koo leads a conversation with medical oncologist Dr. Elisabeth Heath (Mayo Clinic) and genetic counselor Lindsey Byrne (The Ohio State University). 

  • Genetic testing basics: How changes in certain genes can affect prostate cancer, and the difference between germline (inherited) testing and somatic (tumor) testing.
  • Getting tested: Which patients should get each test and how samples are collected
  • Your results: How they could expand treatment options, access to clinical trials, and inform your family members’ cancer risk.
  • A new treatment option: The FDA recently approved capivasertib, taken with abiraterone and prednisone, for patients with metastatic hormone-sensitive prostate cancer whose tumors have low levels of a protein called PTEN, based on somatic testing.

PCF thanks AstraZeneca for their support of this program.

Astra Zeneca logo